The Patented Medicine Prices Review Board has published updated guidelines (news release and introduction) scheduled to take effect January 1, 2021 when the (delayed – see earlier post) amended Regulations are to come into force.
The Supreme Court of Canada is expected to release its leave decision on Thursday in York University v. Access Copyright on copyright tariffs and fair dealing.
In other Supreme Court news, earlier today, the United States Supreme Court granted cert in Arthrex considering the constitutionality of the appointment of USPTO’s PTAB judges and their subsequent decisions.
CIPO has published an updated schedule for the virtual patent agent examination process which was deferred from the spring.
A couple of articles of mine were recently published:
- Pre-Grant Compensation for Patent Infringement on Slaw.ca
- Canadian Patent Office’s approach to computer-implemented inventions rejected by Federal Court co-authored with Richard Mar
I will be a panelist next week at the virtual IPIC AGM with Malaika Tyson, speaking about File Wrapper Estoppel in Canada and the United States.
The Federal Court issued a COVID related Practice Notice today confirming that Practice Directions and Orders issued during the COVID-19 pandemic remain unaffected by the recently enacted Time Limits and Other Periods Act (COVID-19). See the Federal Court of Appeal’s decision last week in Re: Section 6 Of The Time Limits And Other Periods Act, 2020 FCA 137.
The FCA issued a COVID related Practice Notice this week regarding in person, remote and hybrid hearings taking place this fall. It also comments on phase out of the Suspension Period at the FCA and the Time Limits and Other Periods Act (COVID-19). The FCA has been posting cases released from the Suspension Period each week.